Literature DB >> 20615136

Thyroglobulin autoantibodies, thyroid nodules, and new insights into some old questions.

Stefan K G Grebe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615136     DOI: 10.1089/thy.2010.1651

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  4 in total

1.  BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.

Authors:  Trevor E Angell; Melissa G Lechner; Julie K Jang; Adrian J Correa; Jonathan S LoPresti; Alan L Epstein
Journal:  Thyroid       Date:  2014-07-15       Impact factor: 6.568

2.  Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies.

Authors:  Cosimo Durante; Sara Tognini; Teresa Montesano; Fabio Orlandi; Massimo Torlontano; Efisio Puxeddu; Marco Attard; Giuseppe Costante; Salvatore Tumino; Domenico Meringolo; Rocco Bruno; Fabiana Trulli; Maria Toteda; Adriano Redler; Giuseppe Ronga; Sebastiano Filetti; Fabio Monzani
Journal:  Thyroid       Date:  2014-05-21       Impact factor: 6.568

3.  Prognostic value of change in anti-thyroglobulin antibodies after thyroidectomy in patients with papillary thyroid carcinoma.

Authors:  A Ernaga-Lorea; M C Hernández-Morhain; E Anda-Apiñániz; J J Pineda-Arribas; I Migueliz-Bermejo; N Eguílaz-Esparza; A Irigaray-Echarri
Journal:  Clin Transl Oncol       Date:  2017-10-25       Impact factor: 3.405

4.  Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.

Authors:  Narendra Hulikal; Azhagamuthu Re; Manilal Banoth; Amith Kumar Chowhan; Mutheswaraiah Yutla; Alok Sachan
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-02       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.